Page last updated: 2024-10-25

dapsone and Pulmonary Fibrosis

dapsone has been researched along with Pulmonary Fibrosis in 2 studies

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial disease of the lung tissue that causes symptoms such as coughing and asthma."1.72Protective effect of dapsone against bleomycin-induced lung fibrosis in rat. ( Asgardoon, MH; Dehpour, AR; Derakhshan, MH; Noori, T; Sheibani, M; Shirooie, S; Tavangar, SM; Yousefi-Manesh, H, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Yousefi-Manesh, H1
Noori, T1
Asgardoon, MH1
Derakhshan, MH1
Tavangar, SM1
Sheibani, M1
Shirooie, S1
Dehpour, AR1
Farouk, A1
Salman, S1

Other Studies

2 other studies available for dapsone and Pulmonary Fibrosis

ArticleYear
Protective effect of dapsone against bleomycin-induced lung fibrosis in rat.
    Experimental and molecular pathology, 2022, Volume: 124

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bleomycin; Catalase; Dapsone; Disease Models, Anima

2022
Dapsone and doxycycline could be potential treatment modalities for COVID-19.
    Medical hypotheses, 2020, Volume: 140

    Topics: Anti-Inflammatory Agents; Betacoronavirus; Chemotaxis, Leukocyte; Coronavirus Infections; COVID-19;

2020